ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

AACI Summarizes Position On New Core Guidelines

May 16, 1980

NCAB Considering Concept Review Of Large, Expensive Investigator Initiated Proposals

February 16, 1990

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

NCI Tells How It Would Spend FY 1978 Research Money

June 25, 1976

Also in this 8-page issue: White House appoints Koch Industries executive David Koch to the National Cancer Advisory Board. He asks: “How can we make the NCI elephant dance like a ballerina?”

September 17, 2004

I-131 doses highest Near Nevada Test Site, Fallout Study Finds

November 17, 1989